Literature DB >> 21030183

Febrile neutropenia in EDs: the role of an electronic clinical practice guideline.

Charles Lim1, Jaime Bawden, Andrew Wing, Cristina Villa-Roel, David P Meurer, Michael J Bullard, Brian H Rowe.   

Abstract

PURPOSE: Evidence-based clinical practice guidelines (CPGs) for managing febrile neutropenia (FN) are widely available; however, the integration of guidelines into routine practice is often incomplete. This study evaluated the uptake and clinical impact of implementing an electronic CPG on the management and outcomes of patients presenting with FN at 4 urban emergency departments (ED).
METHODS: A retrospective chart review over a 3-year period at 4 hospitals in Edmonton, Alberta, was performed. Potentially eligible patient visits were identified by searching the Ambulatory Care Classification System database using International Classification of Diseases, 10th Edition, codes and ED physician diagnoses of FN. ED patients with fever (>38°C at home or in ED) and neutropenia (white blood cell count of <1000 cells/mm(3) or a neutrophil count of <500 cells/mm(3)) who received an ED diagnosis of FN were included.
RESULTS: From 371 potential cases, 201 unique cases of FN were included. Overall, the electronic CPG was used in 76 (37.8%) of 201 patient visits; however, there were significant differences in CPG utilization between hospitals. Clinical practice guideline usage was greatest at the University of Alberta Hospital (57%). This finding correlated with a decrease in time from triage to first antibiotic by 1 hour compared to the 3 control hospitals (3.9 vs 4.9 hours, P = .022).
CONCLUSIONS: The electronic CPG is a useful clinical tool that can improve patient management in the ED, and strategies to increase its utilization in this and other regions should be pursued.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21030183     DOI: 10.1016/j.ajem.2010.08.011

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN: 0735-6757            Impact factor:   2.469


  6 in total

1.  Association of time to antibiotics and clinical outcomes in patients with fever and neutropenia during chemotherapy for cancer: a systematic review.

Authors:  Christa Koenig; Christine Schneider; Jessica E Morgan; Roland A Ammann; Lillian Sung; Bob Phillips
Journal:  Support Care Cancer       Date:  2019-07-01       Impact factor: 3.603

2.  Standardizing Febrile Neutropenia Management: Antimicrobial Stewardship in the Hematologic Malignancy Population.

Authors:  John C O'Horo; Jasmine R Marcelin; Omar M Abu Saleh; Amelia K Barwise; Patricia M Odean; Christina G Rivera; Aaron J Tande; John W Wilson; Douglas R Osmon; Pritish K Tosh
Journal:  J Oncol Pract       Date:  2019-07-19       Impact factor: 3.840

Review 3.  The Multinational Association for Supportive Care in Cancer (MASCC) risk index score: 10 years of use for identifying low-risk febrile neutropenic cancer patients.

Authors:  Jean Klastersky; Marianne Paesmans
Journal:  Support Care Cancer       Date:  2013-02-27       Impact factor: 3.603

Review 4.  The use of computerized clinical decision support systems in emergency care: a substantive review of the literature.

Authors:  Paula Bennett; Nicholas R Hardiker
Journal:  J Am Med Inform Assoc       Date:  2017-05-01       Impact factor: 4.497

5.  How Quality of Oncology Care and Services be Improved through Leadership and Collaborations: Cross-clusters CQI Program in Hong Kong.

Authors:  Suzanne So-Shan Mak
Journal:  Asia Pac J Oncol Nurs       Date:  2016 Oct-Dec

6.  Independent factors for prediction of poor outcomes in patients with febrile neutropenia.

Authors:  Müge Günalp; Merve Koyunoğlu; Serdar Gürler; Ayça Koca; Ilker Yeşilkaya; Emre Öner; Meltem Akkaş; Nalan Metin Aksu; Arda Demirkan; Onur Polat; Atilla Halil Elhan
Journal:  Med Sci Monit       Date:  2014-10-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.